Intellicell Biosciences, Inc. Proceeds from Notes Payable
Intellicell Biosciences, Inc. reported Proceeds from Notes Payable of $42.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2014-11-19
- Intellicell Biosciences, Inc. proceeds from notes payable for the quarter ending 2014-09-30 was $12.00K, a 94.00% decline year-over-year.
- Intellicell Biosciences, Inc. proceeds from notes payable for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- Intellicell Biosciences, Inc. proceeds from notes payable for the quarter ending 2014-03-31 was $30.00K, a 70.00% decline year-over-year.
- Intellicell Biosciences, Inc. proceeds from notes payable for the quarter ending 2013-12-31 was -$425.00K, a 205.88% decline year-over-year.
- Intellicell Biosciences, Inc. proceeds from notes payable for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Intellicell Biosciences, Inc. proceeds from notes payable for fiscal 2012 was $601.57K.
- Intellicell Biosciences, Inc. proceeds from notes payable for fiscal 2011 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2014-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $12.00K derived: sum of 2 quarters · filed 2014-11-19 | $42.00K 10-Q · filed 2014-11-19 | -$383.00K derived: sum of 4 quarters · filed 2014-11-19 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-10-10 | $30.00K 10-Q · filed 2014-10-10 | -$395.00K derived: sum of 3 quarters · filed 2014-10-10 | -$195.00K derived: sum of 4 quarters · filed 2014-11-19 |
| 2014-03-31 | $30.00K 10-Q · filed 2014-10-09 | -$395.00K derived: sum of 2 quarters · filed 2014-10-09 | -$195.00K derived: sum of 3 quarters · filed 2014-11-19 | -$70.00K derived: sum of 4 quarters · filed 2014-11-19 |
| 2013-12-31 | -$425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-10-09 | -$225.00K derived: sum of 2 quarters · filed 2014-11-19 | -$100.00K derived: sum of 3 quarters · filed 2014-11-19 | $0.00 10-K · filed 2014-10-09 |
| 2013-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $325.00K derived: sum of 2 quarters · filed 2014-11-19 | $425.00K 10-Q · filed 2014-11-19 | $826.40K derived: sum of 4 quarters · filed 2014-11-19 |
| 2013-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-10-10 | $225.00K 10-Q · filed 2014-10-10 | $626.40K derived: sum of 3 quarters · filed 2014-10-10 | |
| 2013-03-31 | $100.00K 10-Q · filed 2014-10-09 | $501.40K derived: sum of 2 quarters · filed 2014-10-09 | ||
| 2012-12-31 | $401.40K derived: 10-K 12 month − 10-Q 9 month · filed 2014-10-09 | $601.57K 10-K · filed 2014-10-09 | ||
| 2012-09-30 | $200.17K 10-Q · filed 2014-10-08 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-09-16 |